Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled a $50 million investment. The Gates Foundation, Novo Nordisk Foundation, and Wellcome on Wednesday announced the launch of a $50 million investment that will focus on comba
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp